A detailed history of Melfa Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Melfa Wealth Management, LLC holds 1,290 shares of ABBV stock, worth $233,670. This represents 0.17% of its overall portfolio holdings.

Number of Shares
1,290
Previous 1,290 -0.0%
Holding current value
$233,670
Previous $221 Million 15.14%
% of portfolio
0.17%
Previous 0.15%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

BUY
$154.79 - $180.76 $7,739 - $9,038
50 Added 4.03%
1,290 $221 Million
Q1 2024

Apr 23, 2024

BUY
$159.82 - $182.1 $198,176 - $225,804
1,240 New
1,240 $226 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $320B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Melfa Wealth Management, LLC Portfolio

Follow Melfa Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Melfa Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Melfa Wealth Management, LLC with notifications on news.